Lido Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.6M | Buy |
78,365
+1,425
| +2% | +$508K | 0.08% | 157 |
|
|
2025
Q4 | $23.7M | Sell |
76,940
-876
| -1% | -$278K | 0.07% | 178 |
|
|
2025
Q3 | $22M | Buy |
77,816
+18,804
| +32% | +$5.45M | 0.07% | 173 |
|
|
2025
Q2 | $16.5M | Buy |
59,012
+1,486
| +3% | +$421K | 0.06% | 182 |
|
|
2025
Q1 | $17.9M | Buy |
57,526
+1,555
| +3% | +$459K | 0.08% | 153 |
|
|
2024
Q4 | $14.6M | Buy |
55,971
+5,459
| +11% | +$1.62M | 0.07% | 172 |
|
|
2024
Q3 | $16.3M | Buy |
50,512
+1,256
| +3% | +$411K | 0.08% | 134 |
|
|
2024
Q2 | $15.4M | Sell |
49,256
-24,602
| -33% | -$7.23M | 0.09% | 124 |
|
|
2024
Q1 | $21M | Buy |
73,858
+5,016
| +7% | +$1.47M | 0.12% | 85 |
|
|
2023
Q4 | $19.8M | Buy |
68,842
+3,035
| +5% | +$827K | 0.13% | 83 |
|
|
2023
Q3 | $17.7M | Buy |
65,807
+26,151
| +66% | +$6.53M | 0.13% | 83 |
|
|
2023
Q2 | $8.8M | Buy |
39,656
+1,594
| +4% | +$370K | 0.06% | 157 |
|
|
2023
Q1 | $9.2M | Sell |
38,062
-17,520
| -32% | -$4.3M | 0.09% | 135 |
|
|
2022
Q4 | $14.6M | Buy |
55,582
+22,525
| +68% | +$6.04M | 0.18% | 70 |
|
|
2022
Q3 | $7.45M | Buy |
33,057
+21,329
| +182% | +$5.17M | 0.09% | 109 |
|
|
2022
Q2 | $2.85M | Sell |
11,728
-1,402
| -11% | -$344K | 0.04% | 183 |
|
|
2022
Q1 | $3.17M | Buy |
13,130
+378
| +3% | +$86.8K | 0.04% | 200 |
|
|
2021
Q4 | $2.87M | Sell |
12,752
-30,658
| -71% | -$6.47M | 0.03% | 221 |
|
|
2021
Q3 | $9.23M | Buy |
43,410
+5,878
| +16% | +$1.35M | 0.13% | 90 |
|
|
2021
Q2 | $9.15M | Buy |
37,532
+2,576
| +7% | +$634K | 0.13% | 99 |
|
|
2021
Q1 | $8.7M | Buy |
34,956
+5,170
| +17% | +$1.23M | 0.15% | 96 |
|
|
2020
Q4 | $6.85M | Buy |
29,786
+21,219
| +248% | +$4.89M | 0.14% | 91 |
|
|
2020
Q3 | $2.18M | Buy |
8,567
+1,181
| +16% | +$293K | 0.06% | 158 |
|
|
2020
Q2 | $1.74M | Buy |
7,386
+963
| +15% | +$220K | 0.05% | 170 |
|
|
2020
Q1 | $1.3M | Sell |
6,423
-289
| -4% | -$63.1K | 0.06% | 191 |
|
|
2019
Q4 | $1.62M | Buy |
6,712
+1,720
| +34% | +$379K | 0.06% | 179 |
|
|
2019
Q3 | $966K | Sell |
4,992
-123
| -2% | -$23.6K | 0.05% | 220 |
|
|
2019
Q2 | $942K | Buy |
5,115
+337
| +7% | +$60.3K | 0.05% | 200 |
|
|
2019
Q1 | $907K | Sell |
4,778
-231
| -5% | -$44.1K | 0.06% | 196 |
|
|
2018
Q4 | $975K | Buy |
5,009
+172
| +4% | +$33.6K | 0.1% | 132 |
|
|
2018
Q3 | $1M | Sell |
4,837
-412
| -8% | -$81.2K | 0.1% | 123 |
|
|
2018
Q2 | $968K | Sell |
5,249
-71
| -1% | -$12.6K | 0.11% | 115 |
|
|
2018
Q1 | $907K | Buy |
5,320
+2,418
| +83% | +$444K | 0.12% | 110 |
|
|
2017
Q4 | $504K | Buy |
2,902
+382
| +15% | +$67.6K | 0.07% | 150 |
|
|
2017
Q3 | $441K | Sell |
2,520
-571
| -18% | -$101K | 0.07% | 159 |
|
|
2017
Q2 | $532K | Buy |
3,091
+102
| +3% | +$16.6K | 0.11% | 110 |
|
|
2017
Q1 | $487K | Buy |
2,989
+157
| +6% | +$26.1K | 0.13% | 106 |
|
|
2016
Q4 | $414K | Buy |
+2,832
| New | +$426K | 0.1% | 107 |
|
|
2016
Q3 | – | Sell |
-1,641
| Closed | -$250K | – | 156 |
|
|
2016
Q2 | $250K | Sell |
1,641
-4,258
| -72% | -$662K | 0.08% | 129 |
|
|
2016
Q1 | $884K | Buy |
+5,899
| New | +$876K | 0.3% | 32 |
|
Other funds holding AMGN
VCM
VPM
Lido Advisors's AMGN Position: Q1 2026 in Review
Lido Advisors increased its Amgen (AMGN) stake by 1.9% in Q1 2026, buying an estimated $508K and bringing the position to 78,365 shares worth $27.6M. The position accounts for 0.08% of the portfolio, ranked #157.
Lido Advisors first reported a position in AMGN in Q1 2016 and has held it in 40 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Lido Advisors held 78,365 shares of Amgen worth $27.6M as of Q1 2026.
- Lido Advisors bought 1,425 Amgen shares in Q1 2026, an estimated $508K.
- Amgen made up 0.08% of Lido Advisors's portfolio in Q1 2026, its #157 holding.
- Lido Advisors first reported a position in Amgen in Q1 2016 and has held it in 40 quarters since.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.